News
At current prices Novo Nordisk is a Strong Buy. It's good positioning in the promising weight loss segment, solid foundation ...
Mumbai: In a serious security and public health concern, several consignments of Novo Nordisk’s injectable medicines — ...
Viking Therapeutics (NASDAQ:VKTX), often touted as an attractive obesity play, shed more than a third of its value this week ...
The monthly cost of a private prescription for Mounjaro is set to exceed £300 from next month – worrying news for the half a ...
FAT jabs can shrink your waistline but can they turbo-boost your bank balance? Rookie investor Megan Norman reveals how she ...
With the new gaming bill, Rathee says e-sports will now be a mainstream career option for those with skill and discipline. "This distinction will help accelerate mainstream adoption, as parents, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results